Maybe the mad tin cap scientist is leading his merry bunch of acolytes up a steep road to the edge of a cliff. Depending on topline those acolytes may soon realize that a company that provides real life 3/4 and 5 year data is far more valuable than a company that has never made those numbers public. There failure to provide these numbers is the real truth behind their science and I believe will be the inevitable undoing of there technology and in the end Novacure as a serious player in the oncology space. The Acolytes will see themselves turn into lemmings as they tumble over the cliff if immunotherapy becomes the chosen science.